Biotechnology News
London-based life science investor Syncona has added two companies to its portfolio, iOnctura and Yellowstone Biosciences. 20 June 2024
Elion Therapeutics, a biotechnology company focusing on invasive fungal infections, has announced the successful closing of an $81 million series B funding round. 17 June 2024
It is not every day that an Italian biotech company raises 23 million euros ($24.7 million) in a Series A financing. 17 June 2024
Exclusive
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.
In Brief
Boston-based biotech firm Ginkgo Bioworks has announced significant workforce reductions as part of its ongoing restructuring efforts. 28 June 2024
Mergers and Acquisitions
Editor's Pick
29 May 2024
Boardroom
28 June 2024
27 June 2024
French biotech MaaT Pharma has appointed Gianfranco Pittari as chief medical officer. 25 June 2024
US biotech Arvinas has promoted Ian Taylor to president of R&D. Angela Cacace will take over from Dr Taylor in his current role of chief scientific officer. 18 June 2024
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze